FSMAX
Price
$114.50
Change
-$1.16 (-1.00%)
Updated
Jun 3 closing price
Net Assets
42.73B
TRMNX
Price
$24.38
Change
-$0.20 (-0.81%)
Updated
Jun 3 closing price
Net Assets
484.38M
Interact to see
Advertisement

FSMAX vs TRMNX

Header iconFSMAX vs TRMNX Comparison
Open Charts FSMAX vs TRMNXBanner chart's image
FSMAX vs TRMNX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. TRMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and TRMNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 42.7B vs. TRMNX (484M). TRMNX pays higher dividends than FSMAX: TRMNX (0.67) vs FSMAX (0.50). FSMAX was incepted earlier than TRMNX: FSMAX (15 years) vs TRMNX (10 years). TRMNX (0.90) is less costly to investors than FSMAX (0.04). TRMNX is a more actively managed with annual turnover of: 39.30 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than TRMNX: FSMAX (0) vs TRMNX (2500). FSMAX annual gain was more profitable for investors over the last year : 30.08 vs. TRMNX (16.93). FSMAX return over 5 years is better than : 37.47 vs. TRMNX (27.89).
FSMAXTRMNXFSMAX / TRMNX
Total Expense Ratio0.040.2713%
Annual Report Gross Expense Ratio0.040.904%
Fund Existence15 years10 years-
Gain YTD14.89011.222133%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets42.7B484M8,822%
Annual Yield % from dividends0.500.6776%
Returns for 1 year30.0816.93178%
Returns for 3 years73.3865.09113%
Returns for 5 years37.4727.89134%
Returns for 10 years143.95157.8891%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMNT0.230.01
+2.24%
Perfect Moment Ltd
JANX13.57-0.21
-1.52%
Janux Therapeutics
KMB94.76-2.73
-2.80%
Kimberly-Clark Corp
SOUN8.07-0.75
-8.47%
SoundHound AI
NRXP4.05-0.58
-12.45%
NRX Pharmaceuticals